Atropine Sulfate

DRUG12 trials

Sponsors

MicroDose Defense Products L.L.C., Baskent University, National Cancer Institute (NCI), Belfast Health and Social Care Trust, Mansoura University

Conditions

Carcinoma In SituCervical Intraepithelial NeoplasiaDexmedetomidineElective Caesarean Section SurgeriesHypertensive Heart DiseaseIntubation ComplicationMyopiaMyopia, Progressive

Phase 1

A Study of Inhaled Atropine Sulfate in Healthy Adults

CompletedNCT00947596

MicroDose Defense Products L.L.C.Organophosphorus Poisoning

Start: 2009-08-31End: 2010-08-31Target: 18Updated: 2010-08-12

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

CompletedNCT02858310

National Cancer Institute (NCI)Carcinoma In Situ, Cervical Intraepithelial Neoplasia, Papillomavirus Infections +2

Start: 2017-01-27End: 2025-07-02Updated: 2026-03-09

Safety, Tolerability and Pharmacodynamics Evaluation of CBT-009 Eye Drop

CompletedNCT05372991

Cloudbreak Therapeutics, LLCMyopia, Progressive

Start: 2022-07-20End: 2023-01-20Updated: 2023-01-27

Phase I Clinical Trial to Evaluate the Safety and Tolerability of Ophtalmic Solution PRO-201

CompletedNCT05470881

Laboratorios Sophia S.A de C.V.Myopia

Start: 2022-08-20End: 2022-12-26Updated: 2026-02-05

Safety and Tolerability Evaluation of PRO-230 Ophthalmic Solution

WithdrawnNCT05481489

Laboratorios Sophia S.A de C.V.Myopia

Start: 2023-02-01End: 2023-04-24Updated: 2024-07-01

Phase 2

Low-dose Atropine Eye Drops to Reduce Progression of Myopia in Children in the United Kingdom

Active, not recruitingNCT03690089

Belfast Health and Social Care TrustMyopia

Start: 2019-04-03End: 2027-02-02Target: 289Updated: 2023-09-07

Dexmedetomidine Infusion Dose Versus Rapid Bolus Dose Before Tracheal Intubation.

RecruitingNCT06327399

Kasr El Aini HospitalDexmedetomidine, Intubation Complication

Start: 2024-01-21End: 2024-05-31Target: 70Updated: 2024-03-25

Phase 3

Intrathecal Levobupivacaine With Opioids for Caesarean Section

CompletedNCT01858090

Baskent UniversityElective Caesarean Section Surgeries

Start: 2009-01-31End: 2010-01-31Updated: 2013-05-21

Study of Atropine Sulfate Eye Drops(0.01%) in Treating Near-work-induced Transient Myopia in Children

CompletedNCT06697522

Ocumension Therapeutics (Suzhou) Co., LtdMyopia

Start: 2023-06-25End: 2024-03-26Updated: 2024-11-20

Phase 4

Intrathecal Atropine vs IV Metoclopramide for Nausea & Vomiting During CS

CompletedNCT03932578

Mansoura UniversityNausea, Vomiting

Start: 2019-05-05End: 2019-08-28Updated: 2019-10-07

Unknown Phase

The Personalized Chinese Herb Formulas Over Hypertensive Bradyarrhythmia

CompletedNCT04505228

Jun XiaoHypertensive Heart Disease

Start: 2020-01-20End: 2020-06-20Updated: 2020-08-10

Adverse Events Related to Low Dose Atropine

CompletedNCT05683535

Scripps HealthMyopia, Progressive

Start: 2018-06-19End: 2023-01-09Updated: 2023-04-25

Related Papers

TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers.

2021-02-08258 citations

Safety and clinical activity of gene-engineered T-cell therapy targeting HPV-16 E7 for epithelial cancers.

Journal of Clinical Oncology2020-05-2020 citations

Low-dose (0.01%) atropine eye-drops to reduce progression of myopia in children: a multicentre placebo-controlled randomised trial in the UK (CHAMP-UK)—study protocol

British Journal of Ophthalmology2019-10-2562 citations

Engineered t cells targeting E7 mediate regression of human papillomavirus cancers in a murine model.

Journal of Clinical Oncology2018-05-205 citations

Engineered T cells targeting E7 mediate regression of human papillomavirus cancers in a murine model

JCI Insight2018-04-18159 citations

Comparison of Intrathecal Levobupivacaine Combined with Sufentanil, Fentanyl, or Placebo for Elective Caesarean Section: A Prospective, Randomized, Double-Blind, Controlled Study

Current Therapeutic Research2013-11-0825 citations